top of page
Ni's Lab-NUS logo

Nucleic Acids Nanotechnologies for RNA Therapy and Gene Editing

We leverage on novel nucleic acids modification techniques and nanotechnologies to improve mRNA therapeutics (RNA vaccines, gene editing)

Our Services

Ni Qianqian, PhD

Asst Professor, Department of Diagnostic Radiology Nanomedicine Translational Research Program

Yong Loo Lin School of Medicine

National University of Singapore


Dr Ni Qianqian NUS

Recent Highlights


Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy

Oct 24, 2023

Wang et al. developed biomimetic nanovaccine with multivalent interleukin-15 self-transpresentation (biNV-IL-15) that allows spatiotemporal manipulation of therapeutic T cells, elicits broad spectrum antigen-specific T cell responses, and promotes cures in multiple syngeneic tumor models with minimal systemic side effects. Read more in Nature Communications.

Materials engineering strategies for cancer vaccine adjuvant development

Materials engineering strategies for cancer vaccine adjuvant development

May 9, 2023

Zhang et al. outlined the current state of materials engineering strategies, including those based on molecular adjuvants, polymers/lipids, inorganic nanoparticles, and bio-derived materials, for adjuvant development. They also elaborate on how these engineering strategies and the physicochemical features of the materials involved influence the effects of adjuvants. Read more in Chemical Society Reviews.


Activatable NIR-II Photothermal Lipid Nanoparticles for Improved Messenger RNA Delivery

April 19, 2023

Li et al. presented second near-infrared (NIR-II) lipid nanoparticles (LNPs) containing pH activatable NIR-II dye conjugated lipid (Cy-lipid) for potentiating mRNA delivery efficiency via a stimulus-responsive photothermal-promoted endosomal escape delivery (SPEED) strategy. Read more in Angewandte Chemie International Edition.

bottom of page